Displaying 25 - 34 items out of 34 results
Press release
… safety. Minimal residual disease (MRD) was assessed using circulating tumor DNA (Guardant Reveal). Mariano Provencio, MD, PhD, Hospital …
ILCN article
Gender Disparity in Lung Cancer
… 2 Jyoti Patel, MD For example, germline mutations in tumor suppressor genes such as TP53, DNA repair pathway genes such as BRCA1, BRCA2, and … these emerging survival patterns, including differences in tumor biology discussed above as well as treatment response …
ILCN article
Circulating Tumor Cell–Derived Patient eXplants: A New Tool for SCLC Research
… Circulating Tumor Cell–Derived Patient eXplants: A New Tool for SCLC …
Press release
… laboratory projects focus on the clonal evolution of tumors, cell-free plasma DNA as biomarkers for early detection, and the role of …
Press release
… demonstrated manageable safety and early signs of anti-tumor activity in patients with relapsed small cell lung … a humanized anti-DLL3 IgG1 monoclonal antibody linked to a DNA topoisomerase I inhibitor via a cleavable linker. Given …
Press release
… biology and its evolution over time, using tools like circulating tumour DNA from liquid biopsies, to match patients to the adjuvant … a targeted therapy,” she stated. “The possibility to study circulating tumour cells from blood samples has been a …
ILCN article
Debaters Argue Merits of Surgery in Malignant Meso in Light of MARS2 Data
… of surgery in the treatment of malignant mesothelioma began circulating. And after a debate at the 2024 Targeted … mesothelioma is maximal cytoreduction to remove all visible tumor, but an R0 resection is not possible. Surgery alone is …
Press release
… Award to Gabriella Sozzi, PhD. Dr. Sozzi leads the Tumor Genomics Unit at Fondazione IRCCS Istituto Nazionale Tumori (INT) in Milan, Italy. She graduated in Biological … of lung cancer in screening programs. In the field of circulating biomarkers, she has a demonstrated record of …
ILCN article
Phase II Trial Evaluates Amivantamab Plus Lazertinib in EGFR-Mutant Lung Cancers With New or Progressing Brain Metastases or Leptomeningeal Disease
… the formal response criteria. However, when we examined CSF circulating tumor cells (CTCs), 67% of patients demonstrated a reduction in tumor burden. This discordance suggests that conventional …